Shenzhen Zhongke Microlight Medical Device Technology Co., Ltd. (hereinafter referred to as "Microlight Medical") completed tens of millions of D2 rounds of financing in October 2022. This round of financing was led by Xingzheng Pharmaceutical Fund and Xingzheng Jinkai Fund under Xingzheng Capital.
It is understood that Microlight Medical was founded in 2012, headquartered in Shenzhen, and has a research and development base in Xi'an. It is a medical industry company incubated and supported by Xi'an Institute of Optics and Mechanics, Chinese Academy of Sciences. Low light level medical care is deeply involved in the field of laser medical technology. It is committed to the independent research and development, global innovation and independent production of minimally invasive laser intervention and innovative medical devices by using the internationally leading photoelectric technology and adhering to the concept of combining medicine with industry.
As a medical industry company oriented by technological innovation, LLL Medical has always adhered to the independent innovation of core technologies and the development of underlying technologies since its establishment, creating a core technology platform composed of three major sectors: ultrafast laser, optical fiber catheter and image processing, and owning more than 140 proprietary intellectual property rights. The company independently developed the Optical Coherence Tomography (OCT) system, which was approved with the NMPA Class III medical device product registration certificate in April 2020, and officially entered the market and successfully commercialized. The independently developed new "multimodal OCT imaging system" was approved in December 2021, which is the first multimodal OCT system approved for clinical application in the coronary OCT field. In the field of laser interventional therapy, many products of the company have entered the pre clinical research stage.
Since its establishment 10 years ago, LLL Medical has developed and produced China's first export scientific research OCT image system, the world's first "multi-mode" OCT image system, the world's first mobile OCT image system, and established the world's first fully automatic OCT optical fiber probe production line. Since the launch of OCT products in 2020, the sales of LLL medical OCT products have grown rapidly and have occupied the leading position of domestic cardiovascular OCT products.
Source: OFweek
